moneydaily.in

Remedium Lifecare Declares Drop In Net Profit, Bags Big Order; Shares To Be In Focus

Tata Stock To Consider Dividend, Emkay Recommends Buy For TP Rs 800

Small cap company Remedium Lifecare Ltd shares will be in focus on February 17, 2025 as the company reported its financial results and bagged an order on Feb 15, 2025. Last trading price of Remedium Lifecare share on Bombay Stock Exchange (BSE) stood at Rs 3.79 per share with intraday gain of 1.88% as on February 14, 2025. The stock hit both upper and lower circuit on February 14, 2025. The stock has been hitting back to back 52-week low value since February 10, 2025.

Meanwhile, the company has a market capitalisation of Rs 152.81 crore and its return on equity (RoE) stood in negative at -107.95%. It is worth mentioning here that Remedium Lifecare shares declined 90.46% from 52-week high price of 38.25 per share. Check key details below:

Remedium Lifecare Declares Drop In Net Profit, Bags Big Order

Remedium Lifecare Bags New Order

As per the exchange filing of Remedium Lifecare dated February 15, 2025, β€œwe are pleased to announce that the Remedium Lifecare Limited has received a multi-year supply contract from renowned pharmaceutical distribution company based in the United Kingdom. This contract encompasses the supply of a range of Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty Chemicals. The estimated value of the supplies scheduled from February 2025 to January 2026 alone is approximately One Hundred Eighty Two Crores Seventy Lakh Rupees only (Rs.182,70,00,000/-).”

Remedium Lifecare Q3 Results

The company declared a steep decline in its net profit for the quarter ended December 2024 at Rs 0.76 crore, down 98.34% year-on-year (YoY) as against Rs 45.82 crore reported in the corresponding quarter of last year. It reported its revenue from operations for Q3FY25 at Rs 38.15 crore from Rs 1834.17 crore declared in the similar quarter of last year. Total income for December 2024 quarter announced at Rs 45.58 crore as against Rs 1848.29 crore in the same quarter of last year. The EPS of Remedium alsoΒ  witnessed significant drop to Rs 0.02 for the quarter ended December 2024 from Rs 22.73 declared in the corresponding quarter of last year.

Remedium Lifecare Shares Performance

The 52-week high price of Remedium Lifecare share on BSE is Rs 38.25 per share (as on 26/02/2024) and 52-week low price is Rs 3.65 per share (as on 14/02/2025), respectively. Remedium Lifecare shares have been witnessing steep fall since last 1-year span as the scrip fell 83.79% when Sensex gained 5.73% during this tenure.

Remedium Lifecare Bonus Share In 2024

Remedium Lifecare declared bonus share in the ratio of 3:1 in 2024 and the company fixed Saturday, July 5, 2024 as the record date. It has recommended bonus shares twice so far since July 28, 2023.

Remedium Lifecare Stock Split In 2024

Remedium Lifecare split the face value of its share twice since September 1, 2023. Remedium Lifecare last split the face value of its shares from Rs 5 to Re 1 in 2024.The share traded ex-split as on February 23, 2024, according to Trendlyne.

Remedium Dividend

The company never recommended any dividend since Jan 1, 2000.

Disclaimer: The story highlights order win Q3 results and should not be considered as investment advice by the Moneydaily.in or the Author.Β  Moneydaily.in and the author will not be held responsible for any losses caused as a result of decisions based on the above information. Moneydaily.in advises readers to do their own research or consult a SEBI registered investment advisor before making any investment decisions.

Recommended: Maharatna BHEL Wins Rs 6700 Cr Order Post Market Hours, Shares Near 52-Week Low

 

Leave a Reply

Your email address will not be published. Required fields are marked *